Suchergebnisse - "Nauck, Michael"

PubPharm (119)

1

A Methodological Framework for Meta-analysis and Clinical Interpretation of Subgroup Data : The Case of Major Adverse Cardiovascular Events With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes

enthalten in: Diabetes care | 2024

von Karagiannis, T. | Tsapas, A. | Bekiari, E. | +2

2

Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease : SURPASS-CVOT design and baseline characteristics

enthalten in: American heart journal | 2024

von Nicholls, S. | Bhatt, D. | Buse, J. | +18

3

Prospective External Validation of an Algorithm Predicting Hourly Basal Insulin Infusion Rates from Characteristics of Patients with Type 1 Diabetes Treated with Insulin Pumps

enthalten in: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association | 2023

von Schmelzer, J. | Kahle-Stephan, M. | Meier, J. | +1

4

Non-peptide, once-per-day oral orforglipron to compete with established peptide-based, injectable GLP-1 receptor agonists

enthalten in: Lancet (London, England) | 2023

von Nauck, M. | Horowitz, M.

CommentOn: Lancet. 2023 Aug 5;402(10400):472-483. - PMID 37369232

5

Impact of concomitant oral glucose-lowering medications on the success of basal insulin titration in insulin-naïve patients with type 2 diabetes : a systematic analysis

enthalten in: BMJ open diabetes research & care | 2023

von Wollenhaupt, D. | Wolters, J. | Abd El Aziz, M. | +1

6

Meta-analysis of head-to-head clinical trials comparing incretin-based glucose-lowering medications and basal insulin : An update including recently developed glucagon-like peptide-1 (GLP-1) receptor agonists and the glucose-dependent insulinotropic polypeptide/GLP-1 receptor co-agonist tirzepatide

enthalten in: Diabetes, obesity & metabolism | 2023

von Nauck, M. | Mirna, A. | Quast, D.

7

CVOT Summit 2022 Report : new cardiovascular, kidney, and glycemic outcomes

enthalten in: Cardiovascular diabetology | 2023

von Schnell, O. | Battelino, T. | Bergenstal, R. | +33

8

Effects of Initial Combinations of Gemigliptin Plus Metformin Compared with Glimepiride Plus Metformin on Gut Microbiota and Glucose Regulation in Obese Patients with Type 2 Diabetes : The INTESTINE Study

enthalten in: Nutrients | 2023

von Lim, S. | Sohn, M. | Florez, J. | +2

9

Therapy of Type 2 Diabetes

enthalten in: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association | 2022

von Landgraf, R. | Aberle, J. | Birkenfeld, A. | +7

10

Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction

enthalten in: Cardiovascular diabetology | 2022

von Nauck, M. | D'Alessio, D.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]